Clinical Trials Directory

Trials / Completed

CompletedNCT01242592

Homeopathy as an Adjuvant to Chemotherapy Improves Clinical Outcome in Relapsed Pulmonary Tuberculosis

Homeopathy as an Adjuvant to Chemotherapy Improves Clinical Outcome in Relapsed Pulmonary Tuberculosis: Randomized Placebo Controlled Trial

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
56 (actual)
Sponsor
NMP Medical Research Institute · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Not accepted

Summary

The purpose of the study is to evaluate the effect of homeopathy as an adjuvant to Anti tuberculosis treatment on sputum conversion, hematological, clinical sign and symptoms of relapsed Pulmonary TB.

Conditions

Interventions

TypeNameDescription
DRUGAnti-Tuberculosis Treatment

Timeline

Start date
2005-02-01
Completion
2008-06-01
First posted
2010-11-17
Last updated
2010-11-17

Locations

1 site across 1 country: India

Source: ClinicalTrials.gov record NCT01242592. Inclusion in this directory is not an endorsement.

Homeopathy as an Adjuvant to Chemotherapy Improves Clinical Outcome in Relapsed Pulmonary Tuberculosis (NCT01242592) · Clinical Trials Directory